News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Ashley A. Mulvihill, MD

Dr Mulvihill is an assistant professor of psychiatry at Case Western Reserve University in Cleveland, Ohio.

Articles by Ashley A. Mulvihill, MD

women's mental health

Preventing Relapse in Schizophrenia: Focus on Women’s Mental Health

BySusan Hatters Friedman, MD, MSt, DFAPA,Ashley A. Mulvihill, MD

June 25th 2026

Estrogen shapes schizophrenia in women: onset peaks, dosing shifts, and relapse risk from periods to pregnancy, postpartum, and menopause.

Latest Updated Articles

Trending on Psychiatric Times

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder

Psychiatric Pharmacogenomics: An Overview

Phase 2 Analysis of ML-004 for Autism Spectrum Disorder Fails to Meet Endpoint

Psychiatric Comorbidities in Adults With Congenital Heart Disease and the Need for Interdisciplinary Care

FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults